Study Results from Public Assistance - Paris Hospitals (AP-HP) Update Understanding of Breast Cancer [Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients ...]

MLA

“Study Results from Public Assistance - Paris Hospitals (AP-HP) Update Understanding of Breast Cancer [Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients ...].” Women’s Health Weekly, Mar. 2022, p. 7139. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.698418505&authtype=sso&custid=ns315887.

APA

Study Results from Public Assistance - Paris Hospitals (AP-HP) Update Understanding of Breast Cancer [Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients ...]. (2022, March 31). Women’s Health Weekly, 7139.

Chicago

Women’s Health Weekly. 2022. “Study Results from Public Assistance - Paris Hospitals (AP-HP) Update Understanding of Breast Cancer [Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients ...],” March 31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.698418505&authtype=sso&custid=ns315887.